INVO Bioscience, VCRM Launch INVOcell Intravaginal System

INVO Bioscience has launched the INVOcell intravaginal culture system, which is intended for fertilization and early embryo development.

The system uses a woman’s “natural incubator,” as opposed to in vitro fertilization in a laboratory, thus simplifying the process and lowering costs, the company says. Further, it has birth rates similar to conventional IVF procedures.

The Virginia Center for Reproductive Medicine is the first to provide the system. — Anisa Jibrell